Loading...

Predilife S.A.

ALPRE.PA•EURONEXT
Healthcare
Medical - Diagnostics & Research
€3.58
€0.13(3.77%)

Predilife S.A. (ALPRE.PA) Company Profile & Overview

Explore Predilife S.A.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Predilife S.A. (ALPRE.PA) Company Profile & Overview

Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOStephane Ragusa

Contact Information

https://www.predilife.com
33 9 53 75 85 43
39, Rue Camille Desmoulins, Villejuif, 94805

Company Facts

19 Employees
IPO DateDec 21, 2018
CountryFR
Actively Trading

Frequently Asked Questions

;